FIELD: medicine.
SUBSTANCE: present invention refers to implanted ophthalmic devices for prolonged drug release in an eye, as well as to a method for making and using such devices. One version of the present invention refers to the device comprising: (a) a main portion accommodating a matrix consisting of prostaglandin and silicone; (b) a parylene coating on an external surface of the main portion; (c) one or more pores arranged on the end of the body which is closest to an anterior side of the eye wherein said pore extends from the external surface of the parylene coating to a surface of an upper portion of the body.
EFFECT: developing the implanted ophthalmic device for prolonged drug release in the eye.
23 cl, 3 ex, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| IMPLANTS OF NASOLACRIMAL DRAINAGE SYSTEM FOR DRUG THERAPY | 2007 |
|
RU2414199C2 |
| DRUG CORES FOR DELAYED RELEASE OF THERAPEUTIC MEANS | 2008 |
|
RU2478366C2 |
| FUSE FOR LACRIMAL POINT WITH EVERGIZED MATRIX CONSISTED OF HOLD-UP CELLS | 2013 |
|
RU2630601C2 |
| NON-INVASIVE MEDICINE DELIVERY TECHNIQUE USING EYE INLAY | 2017 |
|
RU2749426C2 |
| METHOD OF TREATING ELEVATED INTRAOCULAR PRESSURE USING INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEM | 2014 |
|
RU2664686C2 |
| REDUCTION OF INTRAOCULAR PRESSURE BY INTRACHAMBER BIMATOPROST IMPLANTS | 2011 |
|
RU2586298C2 |
| OPHTHALMIC SYSTEM FOR SUSTAINED RELEASE OF DRUG TO EYE | 2013 |
|
RU2652063C2 |
| OPHTHALMIC PHARMACEUTICAL COMPOSITION | 2016 |
|
RU2734344C2 |
| INTRAUTERINE SYSTEM FOR THERAPEUTIC APPLICATION | 2010 |
|
RU2529477C2 |
| INTRAOCULAR DRUG DELIVERY SYSTEMS | 2007 |
|
RU2440102C2 |
